Rx PHARMASIST.CA
The Pharmasist newsletter

Stay current in
Canadian pharmacy.

Pharmacy news, practice updates and fresh perspectives—delivered to your inbox.

Keep your practice informed

  • Canadian pharmacy news

    Follow the developments shaping the profession.

  • Prescriber updates

    Stay informed about newly licensed Ontario physicians.

  • What's new on Pharmasist

    Explore new resources, tools and learning opportunities.

Free newsletter

A useful addition to your inbox.

We'll send a confirmation link first. Privacy policy

All news Pharmasist News & insight

ISMP Canada finds patient harm in 19 of 51 reported hyperkalemia incidents

ISMP Canada’s Nov. 12 review describes treatment delays, insulin mix-ups and missed blood glucose checks in reported acute-care incidents involving high potassium.

2 min read2 sources
Share LinkedIn X Facebook Email
Illustrative photo accompanying this news article
A blood glucose meter during a fingerstick check, shown for illustration. Photo by Roy Zuo via Wikimedia Commons (CC BY-SA 4.0). Image source Image source
In this article & details

Article details

Published
Nov 16, 2026
Reading time
2 min read
Categories
Hospital Pharmacy, Medication Safety
Jurisdiction
National
Sources cited
2
All news

ISMP Canada found that 19 of 51 acute-care medication incidents involving hyperkalemia, or high blood potassium, were reported to have harmed patients. The Nov. 12 bulletin identified communication problems, delays and missed independent checks among the most common contributing factors in the reports that involved harm. ISMP Canada safety bulletin

Reports describe missed monitoring and delayed treatment

Reviewers narrowed 664 records from three reporting programs to 51 relevant reports covering March 2021 through February 2026. The reports describe what went wrong in the cases submitted to those programs. They cannot establish how often errors occur across all patients treated for hyperkalemia. Review methods · Reporting program

Some reports described unnecessary or excessive potassium supplementation. Others described treatment delayed across shift changes or hospital transfers. After intravenous insulin, missing blood glucose checks contributed to severe low blood sugar in some reports. The bulletin also identified confusion between similarly named insulin products. Reported incident patterns

ISMP calls for changes to hospital order sets

The institute recommended building glucose monitoring into hyperkalemia orders, making insulin verification more consistent and improving access to medicines and equipment on care units. It published the findings to help hospitals examine how they order, dispense, administer and monitor treatment. Recommendations in the bulletin

References

  1. Preventing and Managing Hyperkalemia: A Multi-Incident Analysis — Institute for Safe Medication Practices Canada, Safety Bulletin, Vol. 26, Issue 10, Nov. 12, 2026
  2. Healthcare Facilities and Long-Term Care Homes Reporting & Learning — Institute for Safe Medication Practices Canada, Incident reporting and learning program

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.